Celebrating Certified Nurses’ Day! March 19th marks Certified Nurses’ Day, a tribute to the dedication and expertise of nurses who pursue advanced certification to elevate patient care. This day honors Dr. Margretta “Gretta” Madden Styles, a pioneer in nursing certification, whose work has shaped excellence in healthcare. At Illuminate, we are incredibly proud of our certified nurse navigators, whose passion for patient care drives real impact. They seamlessly provide clinical management for over 100,000 patients, ensuring adherence to guidelines for actionable incidental findings. Their commitment to excellence fosters collaboration between patients, providers, and institutions, helping to navigate complex healthcare challenges and improve outcomes. 💙 Join us in recognizing our certified nurse navigators! ✅ Charlene Gist, RN, CCRN – Board-certified in Cardiovascular and Critical Care ✅ Meredith H. Hickerson, RN, CCRN – Certified in Critical Care ✅ Jessica Cline, APRN, FNP-C – Certified in Family Practice as a Nurse Practitioner Thank you for your dedication, compassion, and expertise! Your work transforms lives every day. #CertifiedNursesDay #NursingExcellence #PatientCare #NurseCertification #HealthcareHeroes #IlluminateHealthcare #ClinicalOutcomes #CompassionInCare
关于我们
Illuminate® was created by software engineers with a single purpose in mind: help our clients unlock the patient record stored across multiple EMR systems to instantly deliver actionable intelligence. Today, Illuminate applications lead the way in helping hospital administrators, academia, radiologists, pathologists and many other specialists improve patient care and business practices.
At the core of the Illuminate application set is InSight, which is a vendor-neutral, Google-like search technology that breaks through the information silos across multiple hospital data systems to give you a complete picture – both current and historical – of your patients and practice.
Whether you’re diagnosing a disease, filling out compliance audits, assessing your department’s quality, or identifying chronic disease populations in need of monitoring, Illuminate lets you leverage the history stored in your EMR to deliver the high level of patient care required to succeed in today’s healthcare landscape.
To be comprehensive requires access to the complete record stored across multiple systems. To be actionable requires pinpointing the relevant notes, test results or reports. To be timely requires that this access be nearly instantaneous and Illuminate brings you these capabilities.
We put EMR data to work.
- 网站
-
http://www.illuminate.ai
Illuminate的外部链接
- 所属行业
- 软件开发
- 规模
- 11-50 人
- 总部
- Overland Park，Kansas
- 类型
- 私人持股
- 创立
- 1995
- 领域
- EMR, RIS, and PACS Integration、"google" like search of radiology, pathology, lab, and clinical note data、Patient Follow Up Alerts、patient retention、follow-up management、vascular patient surveillance和Lung Nodule patient surveillance
地点
Illuminate员工
动态
-
Transforming Patient Surveillance Here are 4 reasons why healthcare leaders are scheduling a demo with Illuminate’s Comprehensive Integrated Patient Surveillance Platform: ✅ Automate Surveillance Workflows: Save time and reduce human error with streamlined automation. ✅ Enhance Care Coordination: Empower your team with tools for seamless collaboration. ✅ Retain More Patients: Improving capture and retention will enhance outcomes, and prevent loss to follow-up or delayed diagnoses. ✅ Deliver Measurable ROI: Achieve impactful results backed by externally validated outcomes and cutting-edge AI technology. ✅ Don’t wait—see how Illuminate can revolutionize your workflows and elevate patient care. 👉 Schedule your demo today: https://lnkd.in/gsyCzCUT #HealthcareInnovation #AIinHealthcare #IlluminateAI #PatientCareExcellence #HealthcareTransformation
-
In 2024, pancreatic cancer was projected to take an estimated 51,750 American lives. While asymptomatic in its early stages, pancreatic cancer typically is discovered in later stages when it has become symptomatic. Advances in early detection can increase cancer survival to 44% compared with 3%-16% survival for later-stage diagnoses. Currently, only about 1 in 5 pancreatic cancers are in the early stages when first diagnosed. Illuminate, in partnership with Mayo Clinic, is taking action by applying advanced AI to revolutionize early detection. Our system analyzes imaging, genetic, and clinical data to identify high-risk individuals before a cancer diagnosis is made. Through AI-driven case prioritization and precision medicine strategies, our platform thereby enhances early diagnosis, improving survival rates for these deadly cancers. Let’s lead the fight against cancer together.
-
-
In 2024, lung cancer was projected to take an estimated 125,070 American lives. While asymptomatic in its early stages, lung cancer typically is discovered in later stages when it has become symptomatic. Advances in early detection can increase cancer survival to 65% compared with 9%-37% survival for later-stage diagnoses. Illuminate, in partnership with Mayo Clinic, is taking action by applying advanced AI to revolutionize early detection. Our system analyzes imaging, genetic, clinical data and risk stratification to flag high-risk individuals before a cancer diagnosis is made. Through AI-driven case prioritization and precision medicine strategies, our platform thereby enhances early diagnosis, improving survival rates for these deadly cancers. Let’s lead the fight against cancer together.
-
-
Real-Time Precision Saves Lives Cancer doesn’t wait, and neither should your diagnosis tools. Illuminate’s real-time detection program enables healthcare providers to act swiftly and decisively. With seamless data integration and instant alerts, your team is empowered to make critical decisions with confidence. Illuminate: Supporting precision care when it matters most. #IlluminateAI #RealTimeResults #HealthcareInnovation #CancerDetection #MedicalTech
-
-
Illuminate is revolutionizing cancer care by harnessing the power of AI to improve early detection and patient outcomes. Our technology analyzes vast amounts of medical data—including imaging results, genetics, and electronic health records—to identify high-risk patients potentially before traditional screenings can. But it doesn’t stop there. Once high-risk individuals are flagged, our AI prioritizes cases based on urgency, ensuring rapid follow-up and personalized engagement. Smart reminders and tailored education empower patients to undergo screenings and adopt preventive measures. At Illuminate, we’re working every day to turn early detection into life-saving action. Contact us to discover how technology can improve early detection and save lives. #IlluminateAI #CancerPrevention #AIinHealthcare #DigitalHealth #EarlyDetection #HealthTech
-
-
February is National Cancer Prevention Month—a vital reminder that many cancer cases can be prevented with lifestyle changes and early detection. According to the American Association for Cancer Research, awareness and proactive screening efforts are making a difference. Yet, the fight is far from over. Today, innovative technologies, including AI-driven solutions like those developed by Illuminate, are transforming early cancer detection and improving treatment outcomes nationwide. From enhanced screening methods to real-time patient engagement, technology plays a pivotal role in shaping a more hopeful future in the battle against cancer. (Sources: AACR: https://lnkd.in/gfJ7eFM SEER: https://lnkd.in/e9VSU_y) How is your organization using technology to improve health outcomes?
-
-
We are happy announce our expanded partnership with Viz. This partnership will further the aims to ensure no patient is lost to follow-up. #AIinHealthcare #CerebralAneurysm #EarlyDetection #MedicalTechnology Please read more about the expanded relationship here: https://lnkd.in/gGieD5SB
-
🌟 Exciting News! 🌟 We are thrilled to announce our partnership with Hannibal Regional Health to transform rural healthcare! Rural communities face unique healthcare challenges. Together, we aim to ensure all patients receive timeline diagnosis for incidentally found lung nodules and more. This partnership is a shared commitment to making a real difference in rural health. Stay tuned for updates! #LungNodules #Healthcare #RuralHealth #Partnership #Innovation #CommunityWellness
Hannibal Regional is pleased to announce a new collaboration with Illuminate AI to launch the Illuminate program, aimed at improving lung cancer detection and management. Lung cancer remains a significant health challenge in Missouri. According to the American Cancer Society, lung cancer accounts for about 13% of all new cancer cases in the state and is the leading cause of cancer deaths. In 2021, an estimated 5,550 new cases of lung cancer were diagnosed in Missouri, with approximately 3,340 deaths attributed to the disease. The new Illuminate program at Hannibal Regional utilizes cutting-edge artificial intelligence technology to analyze radiology reports, identifying lung nodules that may require further evaluation. By applying widely accepted guidelines for managing pulmonary nodules, the AI system prioritizes cases needing immediate attention. Dr. Jennifer Minoff, Pulmonary/Critical Care physician at Hannibal Regional, explains, "Illuminate represents a leap forward in our ability to detect and address potential lung cancers early. This will help us more efficiently identify at-risk patients and streamline their care." The new Illuminate program offers a comprehensive approach to patient care, with real-time reviews of radiologist reports, reducing the risk of overlooking potential warning signs. Additionally, nurse navigators proactively engage with patients identified by the system, ensuring timely follow-up care. The program’s primary goals are to increase lung cancer screening rates and improve early detection. Early detection is vital, as the five-year survival rate for localized lung cancer is 61%, compared to only 6% for distant-stage cancer. “Partnering with Illuminate is another way Hannibal Regional is investing in bringing the latest technology to improve the health of our community,” says Dr. Minoff. “This program is one more way we are guiding our patients to better care.” Hannibal Regional plans to expand the use of this technology to identify other conditions such as aneurysms, cysts, and various types of nodules, further enhancing its diagnostic capabilities across multiple areas of care. "We are excited about our partnership with Hannibal Regional to support rural health,” states Cole Erdmann, CEO, Softek Illuminate, Inc. "This comprehensive approach to managing pulmonary nodules will provide a foundation to improving the health of the community.” Hannibal Regional’s investment in this new technology assists in offering the highest quality and most cost-effective care to truly guide patients to BETTER. To contact Hannibal Regional or Dr. Minoff’s office call (573) 629-3500.
-
-
We monitor cerebral aneurysms from detection to treatment. Early detection saves lives. Our innovative Cerebral Aneurysm Program leverages advanced technology to identify aneurysms swiftly and accurately, equipping your medical team with real-time insights for critical decision-making. With real-time alerts and seamless data integration, we help you stay ahead, providing timely interventions and enhancing patient outcomes. Discover in the comments how our Cerebral Aneurysm Program can transform your approach to aneurysm detection and care. #IlluminateAI #NeuroCare #HealthcareInnovation
-